[Patient-controlled analgesia for prolonged pain in the child. An open-label feasibility study of a standardized method]

Arch Pediatr. 2000 May;7(5):474-80. doi: 10.1016/s0929-693x(00)89002-8.
[Article in French]

Abstract

Background: Patient-controlled analgesia (PCA) has been shown to be superior to a continuous morphine infusion for the treatment of ongoing pain in children over five years of age. Nevertheless, prescription parameters such as the bolus dosage and the possible association of a continuous background infusion have not yet been standardized.

Patients and methods: Thirty-three children, aged four to 17, hospitalized in a pediatric hematology ward, benefited from PCA with a standardized prescription: a bolus dosage of at least 25 mg/kg, without a background infusion. Morphine consumption, side effects and efficacy on pain relief were followed.

Results: Median of mean morphine consumption was 0.32 mg.kg-1.d-1. Median of maximal consumption was 0.58 mg.kg-1.d-1. Mean duration was nine days. No important side effects were noted, except in two patients. They presented prolonged constipation and a poor quality of nocturnal sleep, but they also had a major depressive syndrome persisting after resolution of pain. Efficacy was comparable to a continuous intravenous infusion, and nocturnal sleep was of good quality for 31 children.

Conclusion: This standardized technique of PCA can be used extensively in children over five years of age. It can be used as a reference for further studies.

Publication types

  • Clinical Trial
  • English Abstract

MeSH terms

  • Adolescent
  • Analgesia, Patient-Controlled*
  • Analgesics, Opioid / administration & dosage*
  • Child
  • Child, Preschool
  • Female
  • Hospitalization
  • Humans
  • Infusions, Intravenous
  • Male
  • Morphine / administration & dosage*
  • Pain / drug therapy*
  • Prospective Studies

Substances

  • Analgesics, Opioid
  • Morphine